Silo Pharma, Inc.
Silo Pharma, Inc.（SILO）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · SILO · 截至 2026年6月8日
活动摘要
买入笔数
15
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Silo Pharma, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
SILO 季度内部人买卖趋势
SILO 内幕交易卖出 · SILO 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · SILO CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
SILO 高管卖出股份 · SILO 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Dec 15, 2025 | Weisblum Eric CEO · Director | Purchase | 2,500 | $1K | Form 4 |
| Dec 15, 2025 | Weisblum Eric CEO · Director | Purchase | 2,500 | $1K | Form 4 |
| Nov 21, 2025 | Weisblum Eric CEO · Director | Purchase | 1,000 | $365 | Form 4 |
| Nov 20, 2025 | Weisblum Eric CEO · Director | Purchase | 1,000 | $370 | Form 4 |
| Nov 19, 2025 | Weisblum Eric CEO · Director | Purchase | 4,500 | $2K | Form 4 |
| Nov 18, 2025 | Weisblum Eric CEO · Director | Purchase | 7,500 | $3K | Form 4 |
| May 27, 2025 | Weisblum Eric CEO · Director | Purchase | 10,000 | $4K | Form 4 |
| Dec 13, 2024 | Weisblum Eric CEO and President · Director | Purchase | 2,500 | $2K | Form 4 |
| Nov 22, 2024 | Weisblum Eric CEO and President · Director | Purchase | 2,500 | $2K | Form 4 |
| Nov 20, 2024 | Weisblum Eric CEO and President · Director | Purchase | 2,500 | $2K | Form 4 |
| Jun 12, 2024 | Weisblum Eric CEO and President · Director | Purchase | 4,438 | $5K | Form 4 |
| Jun 11, 2024 | Weisblum Eric CEO and President · Director | Purchase | 562 | $607 | Form 4 |
| Apr 5, 2024 | Weisblum Eric CEO and President · Director | Purchase | 400 | $812 | Form 4 |
| Apr 4, 2024 | Weisblum Eric CEO and President · Director | Purchase | 600 | $1K | Form 4 |
| Apr 1, 2024 | Weisblum Eric CEO and President · Director | Purchase | 1,100 | $2K | Form 4 |
| Mar 28, 2024 | Weisblum Eric CEO and President · Director | Purchase | 3,408 | $7K | Form 4 |
| Dec 20, 2023 | Weisblum Eric CEO and President · Director | Purchase | 200 | $322 | Form 4 |
| Dec 19, 2023 | Weisblum Eric CEO and President · Director | Purchase | 500 | $815 | Form 4 |
| Dec 15, 2023 | Weisblum Eric CEO and President · Director | Purchase | 900 | $1K | Form 4 |
| Dec 14, 2023 | Weisblum Eric CEO and President · Director | Purchase | 200 | $300 | Form 4 |
| Dec 7, 2023 | Weisblum Eric CEO and President · Director | Purchase | 324 | $441 | Form 4 |
| Dec 6, 2023 | Weisblum Eric CEO and President · Director | Purchase | 76 | $102 | Form 4 |
| Dec 5, 2023 | Weisblum Eric CEO and President · Director | Purchase | 600 | $834 | Form 4 |
| Nov 30, 2023 | Weisblum Eric CEO and President · Director | Purchase | 1,000 | $2K | Form 4 |
| Nov 29, 2023 | Weisblum Eric CEO and President · Director | Purchase | 1,000 | $2K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 SILO 内幕交易
SILO 内幕交易
Silo Pharma, Inc.（SILO）内幕交易数据来源于公司内部人（包括Weisblum Eric (CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，1位内部人向SEC提交了交易申报。SILO内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Silo Pharma, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
SILO 内幕交易 · 5个问题Silo Pharma, Inc.（SILO）的内部人包括高管和董事，如Weisblum Eric (CEO · Director)等。过去12个月内，1位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026